Chargement en cours...
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
Anti-viral immunity presents a major hurdle for systemically administered oncolytic viruses (OV). Intratumoral OV therapy has a potential to overcome this problem through activation of anti-tumor immune response, with local and abscopal effects. However, the effects of anti-viral immunity in such a...
Enregistré dans:
| Publié dans: | Mol Ther |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Gene & Cell Therapy
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6079372/ https://ncbi.nlm.nih.gov/pubmed/29478729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.01.019 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|